InvestorsHub Logo
Followers 829
Posts 119628
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Tuesday, 12/06/2022 10:24:41 AM

Tuesday, December 06, 2022 10:24:41 AM

Post# of 2961
PFE enlists Clear Creek Bio (private) to develop an oral inhibitor of the SARS-CoV-2 papain-like protease (which is distinct from the SARS-CoV-2 “main” protease that is targeted by Paxlovid):

https://finance.yahoo.com/news/pfizer-clear-creek-bio-collaborate-114500791.html

This collaboration is a tacit admission by PFE that Paxlovid is far from an ideal answer to the question of how endemic COVID should be treated.

Financial terms were not disclosed.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News